Literature DB >> 11207152

Predictive 5-year survivorship model of cystic fibrosis.

T G Liou1, F R Adler, S C Fitzsimmons, B C Cahill, J R Hibbs, B C Marshall.   

Abstract

The objective of this study was to create a 5-year survivorship model to identify key clinical features of cystic fibrosis. Such a model could help researchers and clinicians to evaluate therapies, improve the design of prospective studies, monitor practice patterns, counsel individual patients, and determine the best candidates for lung transplantation. The authors used information from the Cystic Fibrosis Foundation Patient Registry (CFFPR), which has collected longitudinal data on approximately 90% of cystic fibrosis patients diagnosed in the United States since 1986. They developed multivariate logistic regression models by using data on 5,820 patients randomly selected from 11,630 in the CFFPR in 1993. Models were tested for goodness of fit and were validated for the remaining 5,810 patients for 1993. The validated 5-year survivorship model included age, forced expiratory volume in 1 second as a percentage of predicted normal, gender, weight-for-age z score, pancreatic sufficiency, diabetes mellitus, Staphylococcus aureus infection, Burkerholderia cepacia infection, and annual number of acute pulmonary exacerbations. The model provides insights into the complex nature of cystic fibrosis and supplies a rigorous tool for clinical practice and research.

Entities:  

Mesh:

Year:  2001        PMID: 11207152      PMCID: PMC2198936          DOI: 10.1093/aje/153.4.345

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  36 in total

1.  Effects of organizational change in the medical intensive care unit of a teaching hospital: a comparison of 'open' and 'closed' formats.

Authors:  S S Carson; C Stocking; T Podsadecki; J Christenson; A Pohlman; S MacRae; J Jordan; H Humphrey; M Siegler; J Hall
Journal:  JAMA       Date:  1996 Jul 24-31       Impact factor: 56.272

2.  Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment.

Authors:  B Frederiksen; S Lanng; C Koch; N Høiby
Journal:  Pediatr Pulmonol       Date:  1996-03

3.  Cost accounting of adult intensive care: methods and human and capital inputs.

Authors:  T W Noseworthy; E Konopad; A Shustack; R Johnston; M Grace
Journal:  Crit Care Med       Date:  1996-07       Impact factor: 7.598

4.  Identifying treatments that halt progression of pulmonary disease in cystic fibrosis.

Authors:  P B Davis; P J Byard; M W Konstan
Journal:  Pediatr Res       Date:  1997-02       Impact factor: 3.756

5.  Double-lung transplantation in mechanically ventilated patients with cystic fibrosis.

Authors:  G Massard; H Shennib; D Metras; J Camboulives; L Viard; D S Mulder; C I Tchervenkov; J F Morin; R Giudicelli; M Noirclerc
Journal:  Ann Thorac Surg       Date:  1993-05       Impact factor: 4.330

6.  Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications.

Authors:  S Lanng; B Thorsteinsson; C Lund-Andersen; J Nerup; P O Schiøtz; C Koch
Journal:  Acta Paediatr       Date:  1994-01       Impact factor: 2.299

7.  Prediction of mortality in patients with cystic fibrosis.

Authors:  E Kerem; J Reisman; M Corey; G J Canny; H Levison
Journal:  N Engl J Med       Date:  1992-04-30       Impact factor: 91.245

8.  Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Authors:  H J Fuchs; D S Borowitz; D H Christiansen; E M Morris; M L Nash; B W Ramsey; B J Rosenstein; A L Smith; M E Wohl
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

9.  The changing epidemiology of cystic fibrosis.

Authors:  S C FitzSimmons
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

10.  Pseudomonas cepacia in lung transplant recipients with cystic fibrosis.

Authors:  G I Snell; A de Hoyos; M Krajden; T Winton; J R Maurer
Journal:  Chest       Date:  1993-02       Impact factor: 9.410

View more
  182 in total

Review 1.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 2.  Current status of paediatric heart, lung, and heart-lung transplantation.

Authors:  M Burch; P Aurora
Journal:  Arch Dis Child       Date:  2004-04       Impact factor: 3.791

3.  Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.

Authors:  Edith T Zemanick; Brandie D Wagner; J Kirk Harris; Jeffery S Wagener; Frank J Accurso; Scott D Sagel
Journal:  Pediatr Pulmonol       Date:  2010-06

Review 4.  Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2016-08       Impact factor: 9.546

5.  In statistics we trust: Towards the careful derivation and interpretation of meaningful survival estimates in cystic fibrosis.

Authors:  N Mayer-Hamblett; D Polineni; S L Heltshe
Journal:  J Cyst Fibros       Date:  2018-02-01       Impact factor: 5.482

6.  Pulmonary exacerbations and parent-reported outcomes in children <6 years with cystic fibrosis.

Authors:  Lyndia C Brumback; Arthur Baines; Felix Ratjen; Stephanie D Davis; Stephen L Daniel; Alexandra L Quittner; Margaret Rosenfeld
Journal:  Pediatr Pulmonol       Date:  2014-04-29

7.  Gender differences in outcomes of patients with cystic fibrosis.

Authors:  Cayce L Harness-Brumley; Alan C Elliott; Daniel B Rosenbluth; Deepa Raghavan; Raksha Jain
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

8.  Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.

Authors:  Sonya L Heltshe; Christopher H Goss; Valeria Thompson; Scott D Sagel; Don B Sanders; Bruce C Marshall; Patrick A Flume
Journal:  Thorax       Date:  2015-04-24       Impact factor: 9.139

9.  Lung transplantation for cystic fibrosis.

Authors:  Frederick R Adler; Paul Aurora; David H Barker; Mark L Barr; Laura S Blackwell; Otto H Bosma; Samuel Brown; D R Cox; Judy L Jensen; Geoffrey Kurland; George D Nossent; Alexandra L Quittner; Walter M Robinson; Sandy L Romero; Helen Spencer; Stuart C Sweet; Wim van der Bij; J Vermeulen; Erik A M Verschuuren; Elianne J L E Vrijlandt; William Walsh; Marlyn S Woo; Theodore G Liou
Journal:  Proc Am Thorac Soc       Date:  2009-12

10.  High treatment burden in adults with cystic fibrosis: challenges to disease self-management.

Authors:  Gregory S Sawicki; Deborah E Sellers; Walter M Robinson
Journal:  J Cyst Fibros       Date:  2008-10-26       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.